PPARG and multiple sclerosis: According to recent research, Scd1 deficiency promotes the hydrolysis of triglycerides and phosphatidylcholine; this increases the release of DHA to activate the nuclear receptor peroxisome proliferator-activated receptor gamma (PPARγ), which promotes regulatory T cell differentiation and thereby reduces the severity of multiple sclerosis (Grajchen et al., 2023).